Agglutination of Tumor Cells by Serum from Patients and Pregnant Women
Author Information
Author(s): C. Tal, T. Dishon, J. Gross
Primary Institution: The Hebrew University, Hadassah Medical School
Hypothesis
Is there an autoimmune mechanism against tumors reflected in the agglutination of tumor cells by serum from patients and pregnant women?
Conclusion
The study found that sera from patients with malignant diseases and pregnant women showed a high incidence of agglutination of tumor cells.
Supporting Evidence
- 90% of sera from cancer patients caused agglutination of HeLa cells.
- 100% of sera from pregnant women at term showed agglutination.
- Only 16% of sera from patients with chronic diseases showed agglutination.
Takeaway
Doctors found that blood from cancer patients and pregnant women can make tumor cells stick together, which might help in understanding how the body fights cancer.
Methodology
The study involved preparing cell suspensions from various tumors and testing their agglutination with serum samples from patients and pregnant women.
Potential Biases
The testers were unaware of the serum origins, reducing potential bias.
Limitations
The study's conclusions are based on a limited number of serum samples from different sources.
Participant Demographics
The study included 120 patients with proven malignancy, 51 patients with chronic diseases, and 12 pregnant women.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website